88m3
Fast Money & Foreign Objects
The New York Times
34 mins ·
The chairman of the company that makes EpiPens was warned about high prices. He responded by raising both his middle fingers and explained that critics ought to go copulate with themselves.
Outcry Over EpiPen Prices Hasn’t Made Them Lower
Mylan has an effective monopoly on a lifesaving product, which has allowed its leaders to see public outrage as a tax they must pay.
NYTIMES.COM|BY CHARLES DUHIGG

34 mins ·
The chairman of the company that makes EpiPens was warned about high prices. He responded by raising both his middle fingers and explained that critics ought to go copulate with themselves.
Outcry Over EpiPen Prices Hasn’t Made Them Lower
Mylan has an effective monopoly on a lifesaving product, which has allowed its leaders to see public outrage as a tax they must pay.
NYTIMES.COM|BY CHARLES DUHIGG
